nodes	percent_of_prediction	percent_of_DWPC	metapath
Granisetron—CYP3A4—Temozolomide—malignant glioma	0.296	1	CbGbCtD
Granisetron—HTR3A—fourth ventricle—malignant glioma	0.111	0.733	CbGeAlD
Granisetron—Grand mal convulsion—Carmustine—malignant glioma	0.0159	0.0385	CcSEcCtD
Granisetron—Extrapyramidal disorder—Temozolomide—malignant glioma	0.00973	0.0235	CcSEcCtD
Granisetron—Gamma-glutamyltransferase increased—Temozolomide—malignant glioma	0.00891	0.0216	CcSEcCtD
Granisetron—Liver injury—Temozolomide—malignant glioma	0.00871	0.0211	CcSEcCtD
Granisetron—HTR3A—brainstem—malignant glioma	0.00868	0.0574	CbGeAlD
Granisetron—Drug interaction—Carmustine—malignant glioma	0.00817	0.0198	CcSEcCtD
Granisetron—Leukocytosis—Carmustine—malignant glioma	0.00807	0.0195	CcSEcCtD
Granisetron—Hyperbilirubinaemia—Temozolomide—malignant glioma	0.00806	0.0195	CcSEcCtD
Granisetron—Hepatic enzyme increased—Temozolomide—malignant glioma	0.00775	0.0187	CcSEcCtD
Granisetron—HTR3A—telencephalon—malignant glioma	0.00771	0.051	CbGeAlD
Granisetron—Urinary incontinence—Carmustine—malignant glioma	0.00732	0.0177	CcSEcCtD
Granisetron—Urinary incontinence—Temozolomide—malignant glioma	0.00708	0.0171	CcSEcCtD
Granisetron—Coma—Carmustine—malignant glioma	0.00693	0.0168	CcSEcCtD
Granisetron—Abnormal vision—Carmustine—malignant glioma	0.00661	0.016	CcSEcCtD
Granisetron—Abnormal vision—Temozolomide—malignant glioma	0.00639	0.0155	CcSEcCtD
Granisetron—Hyponatraemia—Carmustine—malignant glioma	0.00553	0.0134	CcSEcCtD
Granisetron—Gastrointestinal haemorrhage—Carmustine—malignant glioma	0.0055	0.0133	CcSEcCtD
Granisetron—Liver function test abnormal—Carmustine—malignant glioma	0.00508	0.0123	CcSEcCtD
Granisetron—Hypokalaemia—Carmustine—malignant glioma	0.00501	0.0121	CcSEcCtD
Granisetron—Hypokalaemia—Temozolomide—malignant glioma	0.00484	0.0117	CcSEcCtD
Granisetron—Aspartate aminotransferase increased—Temozolomide—malignant glioma	0.00479	0.0116	CcSEcCtD
Granisetron—Alanine aminotransferase increased—Temozolomide—malignant glioma	0.00469	0.0114	CcSEcCtD
Granisetron—Abdominal distension—Temozolomide—malignant glioma	0.00463	0.0112	CcSEcCtD
Granisetron—HTR3A—central nervous system—malignant glioma	0.00438	0.029	CbGeAlD
Granisetron—Dysuria—Temozolomide—malignant glioma	0.0043	0.0104	CcSEcCtD
Granisetron—Photosensitivity reaction—Temozolomide—malignant glioma	0.0042	0.0102	CcSEcCtD
Granisetron—Urinary tract infection—Carmustine—malignant glioma	0.00412	0.00998	CcSEcCtD
Granisetron—Urinary tract infection—Temozolomide—malignant glioma	0.00398	0.00964	CcSEcCtD
Granisetron—Hepatobiliary disease—Temozolomide—malignant glioma	0.00388	0.00938	CcSEcCtD
Granisetron—Sinusitis—Temozolomide—malignant glioma	0.00385	0.00931	CcSEcCtD
Granisetron—Connective tissue disorder—Carmustine—malignant glioma	0.00374	0.00905	CcSEcCtD
Granisetron—Visual impairment—Carmustine—malignant glioma	0.00367	0.00888	CcSEcCtD
Granisetron—Connective tissue disorder—Temozolomide—malignant glioma	0.00362	0.00875	CcSEcCtD
Granisetron—Visual impairment—Temozolomide—malignant glioma	0.00355	0.00858	CcSEcCtD
Granisetron—Flushing—Carmustine—malignant glioma	0.00353	0.00855	CcSEcCtD
Granisetron—HTR3A—brain—malignant glioma	0.00348	0.023	CbGeAlD
Granisetron—Flushing—Temozolomide—malignant glioma	0.00341	0.00826	CcSEcCtD
Granisetron—Arrhythmia—Carmustine—malignant glioma	0.0034	0.00823	CcSEcCtD
Granisetron—Alopecia—Carmustine—malignant glioma	0.00336	0.00814	CcSEcCtD
Granisetron—Angiopathy—Temozolomide—malignant glioma	0.00334	0.00808	CcSEcCtD
Granisetron—Malnutrition—Carmustine—malignant glioma	0.00331	0.00802	CcSEcCtD
Granisetron—Chills—Temozolomide—malignant glioma	0.0033	0.00799	CcSEcCtD
Granisetron—Alopecia—Temozolomide—malignant glioma	0.00325	0.00787	CcSEcCtD
Granisetron—Malnutrition—Temozolomide—malignant glioma	0.0032	0.00775	CcSEcCtD
Granisetron—CYP2D6—brainstem—malignant glioma	0.00319	0.0211	CbGeAlD
Granisetron—CYP1A1—Xenobiotics—CYP2B6—malignant glioma	0.00316	0.0227	CbGpPWpGaD
Granisetron—Dysgeusia—Temozolomide—malignant glioma	0.00314	0.00759	CcSEcCtD
Granisetron—Tremor—Carmustine—malignant glioma	0.00311	0.00751	CcSEcCtD
Granisetron—Anaemia—Carmustine—malignant glioma	0.00306	0.00741	CcSEcCtD
Granisetron—Agitation—Carmustine—malignant glioma	0.00305	0.00737	CcSEcCtD
Granisetron—Tremor—Temozolomide—malignant glioma	0.003	0.00726	CcSEcCtD
Granisetron—CYP2D6—Fatty acids—CYP2B6—malignant glioma	0.003	0.0215	CbGpPWpGaD
Granisetron—Ill-defined disorder—Temozolomide—malignant glioma	0.00297	0.00719	CcSEcCtD
Granisetron—Leukopenia—Carmustine—malignant glioma	0.00297	0.00718	CcSEcCtD
Granisetron—Anaemia—Temozolomide—malignant glioma	0.00296	0.00716	CcSEcCtD
Granisetron—Agitation—Temozolomide—malignant glioma	0.00294	0.00712	CcSEcCtD
Granisetron—CYP3A5—Xenobiotics—CYP2C18—malignant glioma	0.0029	0.0209	CbGpPWpGaD
Granisetron—Malaise—Temozolomide—malignant glioma	0.00289	0.00699	CcSEcCtD
Granisetron—Vertigo—Temozolomide—malignant glioma	0.00288	0.00696	CcSEcCtD
Granisetron—Leukopenia—Temozolomide—malignant glioma	0.00287	0.00694	CcSEcCtD
Granisetron—Hypertension—Carmustine—malignant glioma	0.00286	0.00693	CcSEcCtD
Granisetron—CYP2D6—telencephalon—malignant glioma	0.00283	0.0187	CbGeAlD
Granisetron—Palpitations—Temozolomide—malignant glioma	0.00283	0.00685	CcSEcCtD
Granisetron—Chest pain—Carmustine—malignant glioma	0.00282	0.00683	CcSEcCtD
Granisetron—Anxiety—Carmustine—malignant glioma	0.00281	0.00681	CcSEcCtD
Granisetron—CYP2D6—Oxidation by Cytochrome P450—POR—malignant glioma	0.0028	0.0201	CbGpPWpGaD
Granisetron—Cough—Temozolomide—malignant glioma	0.0028	0.00676	CcSEcCtD
Granisetron—Hypertension—Temozolomide—malignant glioma	0.00277	0.00669	CcSEcCtD
Granisetron—CYP1A1—Xenobiotics—CYP2C18—malignant glioma	0.00274	0.0197	CbGpPWpGaD
Granisetron—Arthralgia—Temozolomide—malignant glioma	0.00273	0.0066	CcSEcCtD
Granisetron—CYP3A5—Irinotecan Pathway—BCHE—malignant glioma	0.00272	0.0195	CbGpPWpGaD
Granisetron—Anxiety—Temozolomide—malignant glioma	0.00272	0.00658	CcSEcCtD
Granisetron—CYP3A4—Liver X Receptor Pathway—CYP2B6—malignant glioma	0.00271	0.0195	CbGpPWpGaD
Granisetron—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.00271	0.00655	CcSEcCtD
Granisetron—Oedema—Carmustine—malignant glioma	0.00271	0.00655	CcSEcCtD
Granisetron—Discomfort—Temozolomide—malignant glioma	0.00269	0.00652	CcSEcCtD
Granisetron—Infection—Carmustine—malignant glioma	0.00269	0.0065	CcSEcCtD
Granisetron—Dry mouth—Temozolomide—malignant glioma	0.00267	0.00645	CcSEcCtD
Granisetron—Thrombocytopenia—Carmustine—malignant glioma	0.00265	0.00641	CcSEcCtD
Granisetron—HTR3A—Ion channel transport—ATP1B2—malignant glioma	0.00265	0.019	CbGpPWpGaD
Granisetron—Tachycardia—Carmustine—malignant glioma	0.00264	0.00639	CcSEcCtD
Granisetron—Anaphylactic shock—Temozolomide—malignant glioma	0.00261	0.00633	CcSEcCtD
Granisetron—Oedema—Temozolomide—malignant glioma	0.00261	0.00633	CcSEcCtD
Granisetron—Infection—Temozolomide—malignant glioma	0.0026	0.00628	CcSEcCtD
Granisetron—Nervous system disorder—Temozolomide—malignant glioma	0.00256	0.0062	CcSEcCtD
Granisetron—Thrombocytopenia—Temozolomide—malignant glioma	0.00256	0.00619	CcSEcCtD
Granisetron—Skin disorder—Temozolomide—malignant glioma	0.00254	0.00614	CcSEcCtD
Granisetron—Hypotension—Carmustine—malignant glioma	0.00253	0.00612	CcSEcCtD
Granisetron—Hyperhidrosis—Temozolomide—malignant glioma	0.00253	0.00612	CcSEcCtD
Granisetron—Musculoskeletal discomfort—Carmustine—malignant glioma	0.00246	0.00596	CcSEcCtD
Granisetron—Insomnia—Carmustine—malignant glioma	0.00245	0.00592	CcSEcCtD
Granisetron—Paraesthesia—Carmustine—malignant glioma	0.00243	0.00588	CcSEcCtD
Granisetron—Dyspnoea—Carmustine—malignant glioma	0.00241	0.00584	CcSEcCtD
Granisetron—Somnolence—Carmustine—malignant glioma	0.0024	0.00582	CcSEcCtD
Granisetron—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.00238	0.00576	CcSEcCtD
Granisetron—CYP2D6—Xenobiotics—CYP2B6—malignant glioma	0.00238	0.0171	CbGpPWpGaD
Granisetron—Insomnia—Temozolomide—malignant glioma	0.00236	0.00572	CcSEcCtD
Granisetron—Decreased appetite—Carmustine—malignant glioma	0.00235	0.00569	CcSEcCtD
Granisetron—Paraesthesia—Temozolomide—malignant glioma	0.00235	0.00568	CcSEcCtD
Granisetron—Gastrointestinal disorder—Carmustine—malignant glioma	0.00234	0.00565	CcSEcCtD
Granisetron—Dyspnoea—Temozolomide—malignant glioma	0.00233	0.00564	CcSEcCtD
Granisetron—Somnolence—Temozolomide—malignant glioma	0.00232	0.00562	CcSEcCtD
Granisetron—Constipation—Carmustine—malignant glioma	0.00231	0.0056	CcSEcCtD
Granisetron—Pain—Carmustine—malignant glioma	0.00231	0.0056	CcSEcCtD
Granisetron—Dyspepsia—Temozolomide—malignant glioma	0.0023	0.00557	CcSEcCtD
Granisetron—CYP3A5—Constitutive Androstane Receptor Pathway—CYP2B6—malignant glioma	0.0023	0.0165	CbGpPWpGaD
Granisetron—CYP1A1—Tryptophan metabolism—ASMT—malignant glioma	0.00228	0.0164	CbGpPWpGaD
Granisetron—Decreased appetite—Temozolomide—malignant glioma	0.00227	0.0055	CcSEcCtD
Granisetron—Gastrointestinal disorder—Temozolomide—malignant glioma	0.00226	0.00546	CcSEcCtD
Granisetron—Constipation—Temozolomide—malignant glioma	0.00224	0.00541	CcSEcCtD
Granisetron—Pain—Temozolomide—malignant glioma	0.00224	0.00541	CcSEcCtD
Granisetron—CYP1A1—central nervous system—malignant glioma	0.00223	0.0147	CbGeAlD
Granisetron—Feeling abnormal—Carmustine—malignant glioma	0.00223	0.00539	CcSEcCtD
Granisetron—Gastrointestinal pain—Carmustine—malignant glioma	0.00221	0.00535	CcSEcCtD
Granisetron—Feeling abnormal—Temozolomide—malignant glioma	0.00215	0.00521	CcSEcCtD
Granisetron—Abdominal pain—Carmustine—malignant glioma	0.00214	0.00517	CcSEcCtD
Granisetron—Body temperature increased—Carmustine—malignant glioma	0.00214	0.00517	CcSEcCtD
Granisetron—Gastrointestinal pain—Temozolomide—malignant glioma	0.00214	0.00517	CcSEcCtD
Granisetron—Urticaria—Temozolomide—malignant glioma	0.00208	0.00503	CcSEcCtD
Granisetron—Abdominal pain—Temozolomide—malignant glioma	0.00207	0.005	CcSEcCtD
Granisetron—Body temperature increased—Temozolomide—malignant glioma	0.00207	0.005	CcSEcCtD
Granisetron—CYP2D6—Xenobiotics—CYP2C18—malignant glioma	0.00206	0.0148	CbGpPWpGaD
Granisetron—Hypersensitivity—Carmustine—malignant glioma	0.00199	0.00482	CcSEcCtD
Granisetron—Asthenia—Carmustine—malignant glioma	0.00194	0.0047	CcSEcCtD
Granisetron—Hypersensitivity—Temozolomide—malignant glioma	0.00193	0.00466	CcSEcCtD
Granisetron—Asthenia—Temozolomide—malignant glioma	0.00188	0.00454	CcSEcCtD
Granisetron—HTR3A—SIDS Susceptibility Pathways—RUNX3—malignant glioma	0.00187	0.0134	CbGpPWpGaD
Granisetron—Diarrhoea—Carmustine—malignant glioma	0.00185	0.00448	CcSEcCtD
Granisetron—Pruritus—Temozolomide—malignant glioma	0.00185	0.00448	CcSEcCtD
Granisetron—CYP3A4—Oxidation by Cytochrome P450—POR—malignant glioma	0.00183	0.0132	CbGpPWpGaD
Granisetron—Dizziness—Carmustine—malignant glioma	0.00179	0.00433	CcSEcCtD
Granisetron—Diarrhoea—Temozolomide—malignant glioma	0.00179	0.00433	CcSEcCtD
Granisetron—CYP1A1—brain—malignant glioma	0.00177	0.0117	CbGeAlD
Granisetron—Dizziness—Temozolomide—malignant glioma	0.00173	0.00418	CcSEcCtD
Granisetron—HTR3A—SIDS Susceptibility Pathways—MYB—malignant glioma	0.00173	0.0124	CbGpPWpGaD
Granisetron—Vomiting—Carmustine—malignant glioma	0.00172	0.00416	CcSEcCtD
Granisetron—Rash—Carmustine—malignant glioma	0.00171	0.00413	CcSEcCtD
Granisetron—Dermatitis—Carmustine—malignant glioma	0.0017	0.00412	CcSEcCtD
Granisetron—Headache—Carmustine—malignant glioma	0.00169	0.0041	CcSEcCtD
Granisetron—HTR3A—SIDS Susceptibility Pathways—SOX2—malignant glioma	0.00167	0.012	CbGpPWpGaD
Granisetron—Vomiting—Temozolomide—malignant glioma	0.00166	0.00402	CcSEcCtD
Granisetron—Rash—Temozolomide—malignant glioma	0.00165	0.00399	CcSEcCtD
Granisetron—Dermatitis—Temozolomide—malignant glioma	0.00165	0.00399	CcSEcCtD
Granisetron—Headache—Temozolomide—malignant glioma	0.00164	0.00396	CcSEcCtD
Granisetron—CYP3A4—central nervous system—malignant glioma	0.00164	0.0108	CbGeAlD
Granisetron—CYP2D6—central nervous system—malignant glioma	0.00161	0.0107	CbGeAlD
Granisetron—Nausea—Carmustine—malignant glioma	0.00161	0.00389	CcSEcCtD
Granisetron—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL12A—malignant glioma	0.00158	0.0114	CbGpPWpGaD
Granisetron—CYP2D6—cerebellum—malignant glioma	0.00157	0.0104	CbGeAlD
Granisetron—CYP3A4—Xenobiotics—CYP2B6—malignant glioma	0.00156	0.0112	CbGpPWpGaD
Granisetron—Nausea—Temozolomide—malignant glioma	0.00155	0.00376	CcSEcCtD
Granisetron—CYP3A5—Irinotecan Pathway—APC—malignant glioma	0.00148	0.0106	CbGpPWpGaD
Granisetron—CYP1A1—Tryptophan metabolism—CYP2C18—malignant glioma	0.00141	0.0101	CbGpPWpGaD
Granisetron—CYP1A1—Aryl Hydrocarbon Receptor—NF1—malignant glioma	0.00141	0.0101	CbGpPWpGaD
Granisetron—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP2B6—malignant glioma	0.00139	0.00999	CbGpPWpGaD
Granisetron—CYP3A5—Oxidation by Cytochrome P450—CYP2B6—malignant glioma	0.00137	0.00986	CbGpPWpGaD
Granisetron—CYP3A4—Xenobiotics—CYP2C18—malignant glioma	0.00135	0.00969	CbGpPWpGaD
Granisetron—CYP1A1—Cytochrome P450 - arranged by substrate type—CYP2B6—malignant glioma	0.00131	0.00943	CbGpPWpGaD
Granisetron—CYP1A1—Oxidation by Cytochrome P450—CYP2B6—malignant glioma	0.0013	0.00931	CbGpPWpGaD
Granisetron—HTR3A—SIDS Susceptibility Pathways—NTRK2—malignant glioma	0.0013	0.00931	CbGpPWpGaD
Granisetron—HTR3A—SIDS Susceptibility Pathways—YWHAE—malignant glioma	0.0013	0.00931	CbGpPWpGaD
Granisetron—CYP2D6—brain—malignant glioma	0.00128	0.00846	CbGeAlD
Granisetron—CYP3A4—Irinotecan Pathway—BCHE—malignant glioma	0.00126	0.00909	CbGpPWpGaD
Granisetron—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP2C18—malignant glioma	0.00121	0.00866	CbGpPWpGaD
Granisetron—CYP3A5—Oxidation by Cytochrome P450—CYP2C18—malignant glioma	0.00119	0.00854	CbGpPWpGaD
Granisetron—HTR3A—Transmembrane transport of small molecules—COX8A—malignant glioma	0.00115	0.00828	CbGpPWpGaD
Granisetron—CYP1A1—Oxidative Stress—SOD1—malignant glioma	0.00114	0.00818	CbGpPWpGaD
Granisetron—CYP1A1—Cytochrome P450 - arranged by substrate type—CYP2C18—malignant glioma	0.00114	0.00818	CbGpPWpGaD
Granisetron—CYP3A5—Phase 1 - Functionalization of compounds—CYP2B6—malignant glioma	0.00113	0.0081	CbGpPWpGaD
Granisetron—CYP1A1—Oxidation by Cytochrome P450—CYP2C18—malignant glioma	0.00112	0.00807	CbGpPWpGaD
Granisetron—CYP3A4—Tryptophan metabolism—ASMT—malignant glioma	0.00112	0.00806	CbGpPWpGaD
Granisetron—CYP1A1—Oxidative Stress—CAT—malignant glioma	0.00108	0.00777	CbGpPWpGaD
Granisetron—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2B6—malignant glioma	0.00107	0.00768	CbGpPWpGaD
Granisetron—HTR3A—SIDS Susceptibility Pathways—GJA1—malignant glioma	0.00106	0.00765	CbGpPWpGaD
Granisetron—CYP1A1—Phase 1 - Functionalization of compounds—CYP2B6—malignant glioma	0.00106	0.00765	CbGpPWpGaD
Granisetron—HTR3A—Transmembrane transport of small molecules—FTH1—malignant glioma	0.00105	0.00757	CbGpPWpGaD
Granisetron—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2B6—malignant glioma	0.00102	0.00731	CbGpPWpGaD
Granisetron—CYP1A1—Arachidonic acid metabolism—PTGS1—malignant glioma	0.000999	0.00717	CbGpPWpGaD
Granisetron—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL12B—malignant glioma	0.000993	0.00713	CbGpPWpGaD
Granisetron—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2B6—malignant glioma	0.000989	0.0071	CbGpPWpGaD
Granisetron—CYP3A5—Phase 1 - Functionalization of compounds—CYP2C18—malignant glioma	0.000977	0.00702	CbGpPWpGaD
Granisetron—CYP2D6—Oxidation by Cytochrome P450—CYP2B6—malignant glioma	0.000976	0.00701	CbGpPWpGaD
Granisetron—HTR3A—SIDS Susceptibility Pathways—HES1—malignant glioma	0.000929	0.00667	CbGpPWpGaD
Granisetron—CYP1A1—Phase 1 - Functionalization of compounds—CYP2C18—malignant glioma	0.000923	0.00663	CbGpPWpGaD
Granisetron—HTR3A—Transmembrane transport of small molecules—ATP1B2—malignant glioma	0.000921	0.00662	CbGpPWpGaD
Granisetron—HTR3A—Transmembrane transport of small molecules—APOD—malignant glioma	0.000896	0.00644	CbGpPWpGaD
Granisetron—CYP1A1—Estrogen Receptor Pathway—STAT3—malignant glioma	0.000877	0.0063	CbGpPWpGaD
Granisetron—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2C18—malignant glioma	0.000857	0.00616	CbGpPWpGaD
Granisetron—CYP2D6—Oxidation by Cytochrome P450—CYP2C18—malignant glioma	0.000846	0.00608	CbGpPWpGaD
Granisetron—CYP2D6—Phase 1 - Functionalization of compounds—CYP2B6—malignant glioma	0.000802	0.00576	CbGpPWpGaD
Granisetron—HTR3A—SIDS Susceptibility Pathways—HIF1A—malignant glioma	0.000778	0.00559	CbGpPWpGaD
Granisetron—CYP1A1—Tryptophan metabolism—CAT—malignant glioma	0.000768	0.00552	CbGpPWpGaD
Granisetron—CYP3A5—Phase 1 - Functionalization of compounds—PTGS1—malignant glioma	0.000741	0.00532	CbGpPWpGaD
Granisetron—CYP1A1—Aryl Hydrocarbon Receptor Pathway—HES1—malignant glioma	0.00073	0.00524	CbGpPWpGaD
Granisetron—CYP1A1—Phase 1 - Functionalization of compounds—PTGS1—malignant glioma	0.0007	0.00503	CbGpPWpGaD
Granisetron—CYP2D6—Phase 1 - Functionalization of compounds—CYP2C18—malignant glioma	0.000695	0.00499	CbGpPWpGaD
Granisetron—CYP3A4—Tryptophan metabolism—CYP2C18—malignant glioma	0.000693	0.00498	CbGpPWpGaD
Granisetron—CYP3A4—Irinotecan Pathway—APC—malignant glioma	0.000687	0.00493	CbGpPWpGaD
Granisetron—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2B6—malignant glioma	0.000646	0.00464	CbGpPWpGaD
Granisetron—CYP3A4—Oxidation by Cytochrome P450—CYP2B6—malignant glioma	0.000638	0.00458	CbGpPWpGaD
Granisetron—CYP3A5—Biological oxidations—CYP2B6—malignant glioma	0.000599	0.0043	CbGpPWpGaD
Granisetron—CYP3A5—Metapathway biotransformation—CYP2B6—malignant glioma	0.000591	0.00424	CbGpPWpGaD
Granisetron—CYP1A1—Biological oxidations—CYP2B6—malignant glioma	0.000566	0.00406	CbGpPWpGaD
Granisetron—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C18—malignant glioma	0.00056	0.00403	CbGpPWpGaD
Granisetron—CYP1A1—Metapathway biotransformation—CYP2B6—malignant glioma	0.000558	0.00401	CbGpPWpGaD
Granisetron—CYP3A4—Oxidation by Cytochrome P450—CYP2C18—malignant glioma	0.000553	0.00397	CbGpPWpGaD
Granisetron—CYP2D6—Phase 1 - Functionalization of compounds—PTGS1—malignant glioma	0.000527	0.00378	CbGpPWpGaD
Granisetron—CYP3A4—Phase 1 - Functionalization of compounds—CYP2B6—malignant glioma	0.000524	0.00376	CbGpPWpGaD
Granisetron—HTR3A—Ion channel transport—RAF1—malignant glioma	0.000522	0.00375	CbGpPWpGaD
Granisetron—CYP3A5—Biological oxidations—CYP2C18—malignant glioma	0.000519	0.00373	CbGpPWpGaD
Granisetron—CYP3A5—Metapathway biotransformation—CYP2C18—malignant glioma	0.000512	0.00368	CbGpPWpGaD
Granisetron—HTR3A—SIDS Susceptibility Pathways—CXCL8—malignant glioma	0.000505	0.00363	CbGpPWpGaD
Granisetron—CYP1A1—Biological oxidations—CYP2C18—malignant glioma	0.00049	0.00352	CbGpPWpGaD
Granisetron—HTR3A—SIDS Susceptibility Pathways—IL1B—malignant glioma	0.000484	0.00348	CbGpPWpGaD
Granisetron—CYP1A1—Metapathway biotransformation—CYP2C18—malignant glioma	0.000484	0.00347	CbGpPWpGaD
Granisetron—HTR3A—SIDS Susceptibility Pathways—CASP3—malignant glioma	0.000483	0.00347	CbGpPWpGaD
Granisetron—HTR3A—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000459	0.00329	CbGpPWpGaD
Granisetron—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C18—malignant glioma	0.000454	0.00326	CbGpPWpGaD
Granisetron—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IFNG—malignant glioma	0.000427	0.00306	CbGpPWpGaD
Granisetron—CYP2D6—Biological oxidations—CYP2B6—malignant glioma	0.000426	0.00306	CbGpPWpGaD
Granisetron—CYP1A1—Tryptophan metabolism—MDM2—malignant glioma	0.000424	0.00305	CbGpPWpGaD
Granisetron—CYP1A1—Aryl Hydrocarbon Receptor—RAF1—malignant glioma	0.000423	0.00304	CbGpPWpGaD
Granisetron—HTR3A—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000421	0.00303	CbGpPWpGaD
Granisetron—CYP2D6—Metapathway biotransformation—CYP2B6—malignant glioma	0.00042	0.00302	CbGpPWpGaD
Granisetron—CYP3A5—Biological oxidations—GSTT1—malignant glioma	0.00042	0.00302	CbGpPWpGaD
Granisetron—HTR3A—SIDS Susceptibility Pathways—VEGFA—malignant glioma	0.00041	0.00294	CbGpPWpGaD
Granisetron—CYP1A1—Aryl Hydrocarbon Receptor—PTGS2—malignant glioma	0.000409	0.00294	CbGpPWpGaD
Granisetron—HTR3A—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000401	0.00288	CbGpPWpGaD
Granisetron—CYP1A1—Biological oxidations—GSTT1—malignant glioma	0.000397	0.00285	CbGpPWpGaD
Granisetron—CYP3A5—Biological oxidations—PTGS1—malignant glioma	0.000393	0.00283	CbGpPWpGaD
Granisetron—CYP1A1—Arachidonic acid metabolism—PTGS2—malignant glioma	0.000383	0.00275	CbGpPWpGaD
Granisetron—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL1B—malignant glioma	0.000381	0.00273	CbGpPWpGaD
Granisetron—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL2—malignant glioma	0.000379	0.00272	CbGpPWpGaD
Granisetron—CYP3A4—Tryptophan metabolism—CAT—malignant glioma	0.000378	0.00272	CbGpPWpGaD
Granisetron—CYP1A1—Biological oxidations—PTGS1—malignant glioma	0.000372	0.00267	CbGpPWpGaD
Granisetron—CYP2D6—Biological oxidations—CYP2C18—malignant glioma	0.000369	0.00265	CbGpPWpGaD
Granisetron—CYP2D6—Metapathway biotransformation—CYP2C18—malignant glioma	0.000364	0.00261	CbGpPWpGaD
Granisetron—CYP1A1—PPARA activates gene expression—NCOR1—malignant glioma	0.000361	0.00259	CbGpPWpGaD
Granisetron—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—NCOR1—malignant glioma	0.000354	0.00254	CbGpPWpGaD
Granisetron—HTR3A—SIDS Susceptibility Pathways—TNF—malignant glioma	0.000351	0.00252	CbGpPWpGaD
Granisetron—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—malignant glioma	0.000344	0.00247	CbGpPWpGaD
Granisetron—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—malignant glioma	0.000326	0.00234	CbGpPWpGaD
Granisetron—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—malignant glioma	0.000322	0.00231	CbGpPWpGaD
Granisetron—CYP2D6—Biological oxidations—GSTT1—malignant glioma	0.000299	0.00214	CbGpPWpGaD
Granisetron—CYP1A1—Aryl Hydrocarbon Receptor—MYC—malignant glioma	0.000297	0.00213	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—RTEL1—malignant glioma	0.000294	0.00211	CbGpPWpGaD
Granisetron—CYP3A5—Biological oxidations—GSTP1—malignant glioma	0.000291	0.00209	CbGpPWpGaD
Granisetron—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—malignant glioma	0.00029	0.00208	CbGpPWpGaD
Granisetron—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—malignant glioma	0.00029	0.00208	CbGpPWpGaD
Granisetron—CYP3A5—Metapathway biotransformation—GSTP1—malignant glioma	0.000287	0.00206	CbGpPWpGaD
Granisetron—CYP2D6—Biological oxidations—PTGS1—malignant glioma	0.00028	0.00201	CbGpPWpGaD
Granisetron—CYP3A4—Biological oxidations—CYP2B6—malignant glioma	0.000278	0.002	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—RTEL1—malignant glioma	0.000278	0.002	CbGpPWpGaD
Granisetron—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—malignant glioma	0.000276	0.00198	CbGpPWpGaD
Granisetron—CYP1A1—Aryl Hydrocarbon Receptor—TNF—malignant glioma	0.000276	0.00198	CbGpPWpGaD
Granisetron—CYP1A1—Biological oxidations—GSTP1—malignant glioma	0.000275	0.00197	CbGpPWpGaD
Granisetron—CYP3A4—Metapathway biotransformation—CYP2B6—malignant glioma	0.000275	0.00197	CbGpPWpGaD
Granisetron—CYP1A1—Aryl Hydrocarbon Receptor—KRAS—malignant glioma	0.000274	0.00197	CbGpPWpGaD
Granisetron—CYP1A1—Metapathway biotransformation—GSTP1—malignant glioma	0.000271	0.00195	CbGpPWpGaD
Granisetron—CYP1A1—PPARA activates gene expression—PPARG—malignant glioma	0.000259	0.00186	CbGpPWpGaD
Granisetron—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—malignant glioma	0.000253	0.00182	CbGpPWpGaD
Granisetron—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—NCOR1—malignant glioma	0.000244	0.00175	CbGpPWpGaD
Granisetron—CYP3A4—Biological oxidations—CYP2C18—malignant glioma	0.000241	0.00173	CbGpPWpGaD
Granisetron—CYP3A4—Metapathway biotransformation—CYP2C18—malignant glioma	0.000238	0.00171	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—RTEL1—malignant glioma	0.000209	0.0015	CbGpPWpGaD
Granisetron—CYP3A4—Tryptophan metabolism—MDM2—malignant glioma	0.000209	0.0015	CbGpPWpGaD
Granisetron—CYP2D6—Biological oxidations—GSTP1—malignant glioma	0.000207	0.00149	CbGpPWpGaD
Granisetron—CYP2D6—Metapathway biotransformation—GSTP1—malignant glioma	0.000204	0.00147	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	0.000199	0.00143	CbGpPWpGaD
Granisetron—CYP3A4—Biological oxidations—GSTT1—malignant glioma	0.000195	0.0014	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	0.000192	0.00138	CbGpPWpGaD
Granisetron—CYP3A4—Biological oxidations—PTGS1—malignant glioma	0.000183	0.00131	CbGpPWpGaD
Granisetron—HTR3A—Transmembrane transport of small molecules—RAF1—malignant glioma	0.000182	0.00131	CbGpPWpGaD
Granisetron—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—malignant glioma	0.000175	0.00125	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—COX8A—malignant glioma	0.000169	0.00121	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—COX8A—malignant glioma	0.00016	0.00115	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—ASMT—malignant glioma	0.000144	0.00103	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	0.000143	0.00103	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—RTEL1—malignant glioma	0.000137	0.000983	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—ASMT—malignant glioma	0.000136	0.000975	CbGpPWpGaD
Granisetron—CYP3A4—Biological oxidations—GSTP1—malignant glioma	0.000135	0.000972	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—BCAN—malignant glioma	0.000135	0.00097	CbGpPWpGaD
Granisetron—CYP3A4—Metapathway biotransformation—GSTP1—malignant glioma	0.000133	0.000958	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	0.000133	0.000953	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—BCAN—malignant glioma	0.000128	0.000917	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—COX8A—malignant glioma	0.00012	0.000863	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—IDH2—malignant glioma	0.000109	0.000782	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—IDH2—malignant glioma	0.000103	0.000739	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—CYP2B6—malignant glioma	0.000102	0.000735	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—ASMT—malignant glioma	0.000102	0.000734	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	9.7e-05	0.000697	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—CYP2B6—malignant glioma	9.67e-05	0.000695	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—BCAN—malignant glioma	9.61e-05	0.00069	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—IDH1—malignant glioma	9.37e-05	0.000673	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—SPHK1—malignant glioma	9.06e-05	0.000651	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—CYP2C18—malignant glioma	8.88e-05	0.000638	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—IDH1—malignant glioma	8.85e-05	0.000635	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—SPHK1—malignant glioma	8.56e-05	0.000615	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—CYP2C18—malignant glioma	8.39e-05	0.000602	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	7.91e-05	0.000568	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—COX8A—malignant glioma	7.86e-05	0.000564	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—IDH2—malignant glioma	7.74e-05	0.000556	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—CYP2B6—malignant glioma	7.28e-05	0.000523	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	7.2e-05	0.000517	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—GSTT1—malignant glioma	7.18e-05	0.000516	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	6.95e-05	0.000499	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—GSTT1—malignant glioma	6.78e-05	0.000487	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—PTGS1—malignant glioma	6.73e-05	0.000483	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—ASMT—malignant glioma	6.68e-05	0.00048	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—IDH1—malignant glioma	6.66e-05	0.000478	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—SPHK1—malignant glioma	6.44e-05	0.000463	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—PTGS1—malignant glioma	6.36e-05	0.000457	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	6.33e-05	0.000455	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—CYP2C18—malignant glioma	6.31e-05	0.000453	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—BCAN—malignant glioma	6.28e-05	0.000451	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—BCHE—malignant glioma	6.26e-05	0.000449	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—SLC5A5—malignant glioma	6.18e-05	0.000444	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—BCHE—malignant glioma	5.91e-05	0.000424	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—SLC5A5—malignant glioma	5.84e-05	0.000419	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	5.52e-05	0.000396	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	5.47e-05	0.000393	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—GSTT1—malignant glioma	5.11e-05	0.000367	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—IDH2—malignant glioma	5.06e-05	0.000364	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—GSTP1—malignant glioma	4.98e-05	0.000357	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—CAT—malignant glioma	4.84e-05	0.000348	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—PTGS1—malignant glioma	4.78e-05	0.000344	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	4.77e-05	0.000343	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—CYP2B6—malignant glioma	4.76e-05	0.000342	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—GSTP1—malignant glioma	4.7e-05	0.000338	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—CAT—malignant glioma	4.58e-05	0.000329	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—NCOR1—malignant glioma	4.57e-05	0.000328	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—BCHE—malignant glioma	4.45e-05	0.000319	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—SLC5A5—malignant glioma	4.39e-05	0.000316	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—IDH1—malignant glioma	4.35e-05	0.000313	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—NCOR1—malignant glioma	4.32e-05	0.00031	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—SPHK1—malignant glioma	4.21e-05	0.000303	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—CYP2C18—malignant glioma	4.13e-05	0.000296	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—CAV1—malignant glioma	3.73e-05	0.000268	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—GSTP1—malignant glioma	3.54e-05	0.000254	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—CAV1—malignant glioma	3.52e-05	0.000253	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—CAT—malignant glioma	3.44e-05	0.000247	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—PIK3CG—malignant glioma	3.4e-05	0.000244	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	3.37e-05	0.000242	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—GSTT1—malignant glioma	3.34e-05	0.00024	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—PPARG—malignant glioma	3.28e-05	0.000235	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—NCOR1—malignant glioma	3.25e-05	0.000234	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—PIK3CG—malignant glioma	3.21e-05	0.00023	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—PTGS1—malignant glioma	3.13e-05	0.000225	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—PPARG—malignant glioma	3.1e-05	0.000222	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—PIK3CD—malignant glioma	2.99e-05	0.000214	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—BCHE—malignant glioma	2.91e-05	0.000209	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—SLC5A5—malignant glioma	2.87e-05	0.000206	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—PIK3CD—malignant glioma	2.82e-05	0.000203	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—CAV1—malignant glioma	2.65e-05	0.00019	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—PIK3CB—malignant glioma	2.6e-05	0.000187	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—PTGS2—malignant glioma	2.58e-05	0.000185	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—PIK3CB—malignant glioma	2.46e-05	0.000177	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—PTGS2—malignant glioma	2.44e-05	0.000175	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—PIK3CG—malignant glioma	2.41e-05	0.000173	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—PPARG—malignant glioma	2.33e-05	0.000167	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—GSTP1—malignant glioma	2.31e-05	0.000166	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—CAT—malignant glioma	2.25e-05	0.000162	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—PTEN—malignant glioma	2.25e-05	0.000162	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—NCOR1—malignant glioma	2.13e-05	0.000153	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—PTEN—malignant glioma	2.12e-05	0.000153	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—PIK3CD—malignant glioma	2.12e-05	0.000152	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—PIK3CB—malignant glioma	1.85e-05	0.000133	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—PTGS2—malignant glioma	1.83e-05	0.000132	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—CAV1—malignant glioma	1.73e-05	0.000124	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—PTEN—malignant glioma	1.6e-05	0.000115	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—PIK3CA—malignant glioma	1.59e-05	0.000114	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—PIK3CG—malignant glioma	1.58e-05	0.000113	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—PPARG—malignant glioma	1.52e-05	0.000109	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—PIK3CA—malignant glioma	1.5e-05	0.000108	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—PIK3CD—malignant glioma	1.39e-05	9.97e-05	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—AKT1—malignant glioma	1.3e-05	9.31e-05	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—AKT1—malignant glioma	1.22e-05	8.79e-05	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—PIK3CB—malignant glioma	1.21e-05	8.69e-05	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—PTGS2—malignant glioma	1.2e-05	8.61e-05	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—PIK3CA—malignant glioma	1.13e-05	8.1e-05	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—PTEN—malignant glioma	1.05e-05	7.51e-05	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—AKT1—malignant glioma	9.21e-06	6.62e-05	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—PIK3CA—malignant glioma	7.37e-06	5.3e-05	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—AKT1—malignant glioma	6.02e-06	4.33e-05	CbGpPWpGaD
